Abstract
AbstractMultiple myeloma (MM) is considered to be one of the hematological malignancies formed by excessive and abnormal proliferation of plasmocytes. Among other parameters, several blood tests are used to diagnose multiple myeloma. The hemorheological profile in multiple myeloma is not widely studied. Hemorheology includes the study of measuring the deformability and aggregation of erythrocytes, blood viscosity, and sedimentation rate. The degree of deformability of blood cells is necessary to maintain proper vital functions. Proper deformability of red blood cells ensures proper blood circulation, tissue oxidation and carbon dioxide uptake. The aim of the study was to compare morphology and blood rheology parameters in patients with MM and healthy individuals. The study included 33 patients with MM, and 33 healthy subjects of the same age. The hematological blood parameters were evaluated using ABX MICROS 60 hematology analyzer. The LORCA Analyzer to study erythrocyte aggregation and deformability. Patients with MM had lower red blood cells count (RBC) (9.11%) (p < 0.001) and half time of total aggregation (T1/2) (94.29%) (p < 0.001) values and higher mean corpuscular volume (MCV) (5.50%) (p < 0.001), aggregation index (AI) (68.60%) (p < 0.001), total extent of aggregation (AMP) (87.92%) (p < 0.001) values than the healthy control group. Aggregation in patients with MM is different compared to healthy individuals. It was observed that the percentage of cell aggregation is almost 50% higher than in the control group. The study of morphology, aggregation and deformability of erythrocytes in patients with suspected MM may be helpful in making clinical decisions.
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Caers, J. et al. European Myeloma Network recommendations on tools for the diagnosis and monitoring of multiple myeloma: What to use and when. Haematologica. 103(11), 1772–1784. https://doi.org/10.3324/haematol.2018.189159 (2018).
2. Woźniak, K., Ratuszek-Sadowska, D., Szostak, M., Nowacka, A. & Śniegocki, M. Chronic pain in the thoracic spine as a symptom of multiple myeloma—case report. J. Educ. Health Sport. 7(5), 218–224 (2017).
3. Giannopoulos, K. et al. Zalecenia Polskiej Grupy Szpiczakowej Dotyczące Rozpoznawania i LeczeniaSzpiczaka Plazmocytowego Oraz Innych Dyskrazji Plazmocytowych Na Rok 2021; (Polska Grupa Szpiczakowa: 2020).
4. Padala, S. A. et al. Epidemiology, staging, and management of multiple myeloma. Med. Sci. 9(1), 3. https://doi.org/10.3390/medsci9010003 (2021).
5. Jurczyszyn, A. & Płatek, P. Szpiczak plazmocytowy—diagnostyka i leczenie. Państwo i Społeczeństwo 21(1), 77–85. https://doi.org/10.48269/2451-0858-pis-2021-1-007 (2021).